or Try an Advanced Search...

    Specialty Drugs Stocks List

    Symbol Grade Name % Change
    OTLK F Outlook Therapeutics, Inc. -2.52
    PRTC C PureTech Health plc 2.86
    RAPT F RAPT Therapeutics, Inc. 8.00
    RZLT B Rezolute, Inc. 10.32
    TAK F Takeda Pharmaceutical Company Limited -0.41
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Care Plans Medical Care Medical Devices
    Related Stock Lists: Biopharmaceutical Biotechnology Life Sciences Immunology Monoclonal Antibody Cancer Cancer Treatment Medicine Pharmacy Age Related Macular Degeneration Alzheimer's Disease Antibodies Arcturus Therapeutics Biology Biomarker Technology Biomarkers Cancer Center Central Nervous System Disorders Choline Chronic Disease

    Related ETFs - A few ETFs which own one or more of the above listed Specialty Drugs stocks.

    Symbol Grade Name Weight
    PPH B Market Vectors Pharmaceutical ETF 4.03
    FLCO C Franklin Liberty Investment Grade Corporate ETF 1.02
    GERM B ETFMG Treatments Testing and Advancements ETF 0.75
    CNCR D Loncar Cancer Immunotherapy ETF 0.65
    FLCB C Franklin Liberty U.S. Core Bond ETF 0.34
    View all Specialty Drugs ETFs...
    Compare ETFs
    Compare FLCO to FLCB Compare GERM to FLCB Compare PPH to FLCO

        Specialty Drugs Stocks Recent News

        Date Stock Title
        May 20 RAPT RAPT Therapeutics: Dip Following FDA Clinical Hold Creates Asymmetric Opportunity
        May 20 PRTC PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share
        May 17 OTLK Q2 2024 Outlook Therapeutics Inc Earnings Call
        May 16 OTLK Outlook Therapeutics, Inc. (OTLK) Q2 2024 Earnings Call Transcript
        May 16 RZLT Rezolute reports Q3 results
        May 16 TAK Takeda Canada Inc. concludes Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) for LIVTENCITY® (maribavir) for the treatment of adults with a post-transplant cytomegalovirus (CMV) infection
        May 16 TAK Takeda’s dengue vaccine obtains WHO prequalification
        May 15 OTLK Outlook Therapeutics reports Q2 results
        May 15 OTLK Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corporate Update
        May 15 RZLT Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update
        May 15 TAK Takeda dengue vaccine gets WHO clearance
        May 14 RAPT Wolfe downgrades RAPT, but still sees "immense" upside potential
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Care Plans Medical Care Medical Devices
        Related Stock Lists: Biopharmaceutical Biotechnology Life Sciences Immunology Monoclonal Antibody Cancer Cancer Treatment Medicine Pharmacy Age Related Macular Degeneration Alzheimer's Disease Antibodies Arcturus Therapeutics Biology Biomarker Technology Biomarkers Cancer Center Central Nervous System Disorders Choline Chronic Disease
        Specialty Drugs

        Specialty drugs are medications that are used to treat complex and chronic conditions, such as cancer, multiple sclerosis, and rheumatoid arthritis. They are typically more expensive than traditional medications and require special handling, storage, and administration. Specialty drugs may also require special monitoring and close follow-up with a healthcare provider.

        Browse All Tags